Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001
Authors not listed
Affiris AG · 2008
Abstract
The purpose of this study is to assess the long-term tolerability and -safety of AFFITOPE AD01 applied during AFFiRiS 001
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2008). Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001. <em>Affiris AG</em>. https://clinicaltrials.gov/study/NCT00711139
Vancouver
Anonymous. Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001. Affiris AG. 2008.
BibTeX
@misc{anon2008PhaseI,
title = {Phase Ib Follow-up Study to Evaluate Long-term Safety and Tolerability of Immunization With AFFITOPE AD01 Applied During AFFiRiS 001},
author = {Anonymous},
journal = {Affiris AG},
year = {2008},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Eye 1994
Citation only
Evolution of soft drusen in age-related macular degeneration
European Spine Journal 2003
Open access · OA
Overview of osteoporosis: pathophysiology and determinants of bone strength
Frontiers in immunology
Open access · OA
Immunosenescence and bone remodeling: from immune cell senescence to skeletal aging through the bone marrow microenvironment
Cell 2013
Open access · OA
The NAD+/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling
AGE 2000
Open access · OA
Metabolic mechanisms of longevity: Caloric restriction in mammals and longevity mutations in Caenorhabditis elegans; a common pathway??
Journal of Ethnopharmacology 2026
Citation only